MedMira's market value is the price at which a share of MedMira trades on a public exchange. It measures the collective expectations of MedMira investors about its performance. MedMira is trading at 0.0574 as of the 27th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0574. With this module, you can estimate the performance of a buy and hold strategy of MedMira and determine expected loss or profit from investing in MedMira over a given investment horizon. Check out MedMira Correlation, MedMira Volatility and MedMira Alpha and Beta module to complement your research on MedMira.
Please note, there is a significant difference between MedMira's value and its price as these two are different measures arrived at by different means. Investors typically determine if MedMira is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MedMira's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MedMira 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedMira's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedMira.
0.00
10/28/2024
No Change 0.00
0.0
In 30 days
11/27/2024
0.00
If you would invest 0.00 in MedMira on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding MedMira or generate 0.0% return on investment in MedMira over 30 days. MedMira is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and tech... More
MedMira Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedMira's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedMira upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedMira's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedMira's standard deviation. In reality, there are many statistical measures that can use MedMira historical prices to predict the future MedMira's volatility.
MedMira is out of control given 3 months investment horizon. MedMira has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate data for seventeen different technical indicators, which can help you to evaluate if expected returns of 5.1% are justified by taking the suggested risk. Use MedMira Mean Deviation of 9.7, risk adjusted performance of 0.106, and Standard Deviation of 38.68 to evaluate company specific risk that cannot be diversified away. MedMira holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -5.72, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MedMira are expected to decrease by larger amounts. On the other hand, during market turmoil, MedMira is expected to outperform it. Use MedMira information ratio, as well as the relationship between the skewness and day typical price , to analyze future returns on MedMira.
Correlation Coefficient
0.0
Spearman Rank Test
-0.06
Residual Average
0.0
Price Variance
0.0
MedMira lagged returns against current returns
Autocorrelation, which is MedMira pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MedMira's pink sheet expected returns. We can calculate the autocorrelation of MedMira returns to help us make a trade decision. For example, suppose you find that MedMira has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
MedMira regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MedMira pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MedMira pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MedMira pink sheet over time.
Current vs Lagged Prices
Timeline
MedMira Lagged Returns
When evaluating MedMira's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MedMira pink sheet have on its future price. MedMira autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MedMira autocorrelation shows the relationship between MedMira pink sheet current value and its past values and can show if there is a momentum factor associated with investing in MedMira.
Other Information on Investing in MedMira Pink Sheet
MedMira financial ratios help investors to determine whether MedMira Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.